| Pharmaceutical Information |
| Drug Name |
Desloratadine |
| Drug ID |
BADD_D00615 |
| Description |
Desloratadine is a second generation, tricyclic antihistamine that which has a selective and peripheral H1-antagonist action. It is the active descarboethoxy metabolite of loratidine (a second generation histamine). Desloratidine has a long-lasting effect and does not cause drowsiness because it does not readily enter the central nervous system. |
| Indications and Usage |
For the relief of symptoms of seasonal allergic rhinitis, perennial (non-seasonal) allergic rhinitis. Desloratidine is also used for the sympomatic treatment of pruritus and urticaria (hives) associated with chronic idiopathic urticaria. |
| Marketing Status |
approved; investigational |
| ATC Code |
R06AX27 |
| DrugBank ID |
DB00967
|
| KEGG ID |
D03693
|
| MeSH ID |
C121345
|
| PubChem ID |
124087
|
| TTD Drug ID |
D01GBY
|
| NDC Product Code |
53104-7613; 55111-360; 52408-0130; 66577-018; 68180-153; 62993-0805; 75895-0099; 78206-188; 65015-698; 69543-107; 71335-1000; 65691-0057; 66039-830; 50090-3975; 78206-119; 53104-7688; 62331-019; 50090-4794; 62250-619; 42291-240; 55111-551; 55111-073 |
| UNII |
FVF865388R
|
| Synonyms |
desloratadine | descarboethoxyloratadine | SCH 34117 | SCH-34117 | Clarinex | Neoclarityn | Aerius | descarboethoxyloratadine acetate |
|
| Chemical Information |
| Molecular Formula |
C19H19ClN2 |
| CAS Registry Number |
100643-71-8 |
| SMILES |
C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4 |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
